Filing Details

Accession Number:
0001493152-22-004599
Form Type:
5
Zero Holdings:
No
Publication Time:
2022-02-14 18:36:36
Reporting Period:
2021-12-31
Accepted Time:
2022-02-14 18:36:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552189 Panacea Life Sciences Holdings Inc. PLSH Medicinal Chemicals & Botanical Products (2833) 271085858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866792 Leslie Buttorff 5910 South University Blvd, C18-193
Greenwood Village CO 80121
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-21 500 $1.00 600,399 No 5 P Direct
Common Stock Acquisiton 2021-12-21 1,000 $0.90 601,399 No 5 P Direct
Common Stock Disposition 2021-10-25 7,321,429 $0.00 4,047,054 No 5 D Indirect Held by Quintel-MC, Incorporated
Series C-2 Preferred Stock Acquisiton 2021-10-25 100 $0.00 100 No 5 A Indirect Held by Quintel-MC, Incorporated
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
No 5 P Direct
No 5 D Indirect Held by Quintel-MC, Incorporated
No 5 A Indirect Held by Quintel-MC, Incorporated
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Series C Preferred Stock 1,000,000 Indirect Held by Quintel-MC, Incorporated
Series C-1 Preferred Stock 10,000 Indirect Held by Quintel-MC, Incorporated
Series D Preferred Stock 10,000 Indirect Held by J&N Real Estate Company LLC
Footnotes
  1. The shares of common stock were cancelled in connection with the designation of 100 shares of Series C-2 Convertible Preferred Stock to Quintel-MC, Incorporated.
  2. The Series C-2 designates 100 shares for issuance, par value $0.0001 per share. Each share of Series C-2 is convertible into 73,215 shares of the Company's common stock and is entitled to vote on all matters submitted to the Company's stockholders on an as-converted basis. Other than the conversion and voting rights, there are no other preferences.
  3. The shares of preferred stock were acquired in connection with the cancellation of 7,321,429 shares of the Company's common stock that were held by Quintel-MC, Incorporated.